The Federal Trade Commission Act, as amended by the Wheeler-Lea Act of March 21, 1938,1 forbids the dissemination of false advertisements to induce the sale of foods, drugs, diagnostic and therapeutic devices and cosmetics in interstate and foreign commerce and in commerce in the District of Columbia or in any territory. It provides, however, that—
No advertisement of a drug shall be deemed to be false if it is disseminated only to members of the medical profession, contains no false representation of a material fact, and includes, or is accompanied in each instance by truthful disclosure of, the formula showing quantitatively each ingredient of such drug.2
The only discoverable purpose of this provision of the act is to establish one rule of interpretation for the determination of the truth or falsity of advertisements of drugs when the advertisements are disseminated only to members of the medical profession and another
DISCLOSURE OF DRUG FORMULAS UNDER FEDERAL TRADE COMMISSION ACT. JAMA. 1938;110(22):1840. doi:10.1001/jama.1938.02790220042016
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: